Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Animalcare ( (GB:ANCR) ) has issued an announcement.
Animalcare reported a strong 2025 trading performance, with revenues up 20% to about £89.1m and underlying EBITDA rising roughly 50%, driven by the successful acquisition and integration of Randlab, double‑digit growth in flagship companion animal brands such as Daxocox, and a sharply expanded equine franchise that now accounts for nearly a quarter of group sales. The company underscored its solid balance sheet and cash generation, continued execution across its three strategic pillars of organic growth, M&A and new product development, and a bolstered R&D pipeline of five key projects including the VHH NGF antibody programme and a new equine biologics technology licence, positioning the Group for accelerated, sustainable growth and setting the stage for a March capital markets event to showcase its plans to investors.
The most recent analyst rating on (GB:ANCR) stock is a Hold with a £270.00 price target. To see the full list of analyst forecasts on Animalcare stock, see the GB:ANCR Stock Forecast page.
Spark’s Take on GB:ANCR Stock
According to Spark, TipRanks’ AI Analyst, GB:ANCR is a Neutral.
Animalcare’s overall stock score reflects strong financial stability and positive corporate events, which are offset by valuation concerns due to a negative P/E ratio. Technical indicators suggest moderate potential for price appreciation. The company’s strategic initiatives and director’s confidence are significant positives.
To see Spark’s full report on GB:ANCR stock, click here.
More about Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation focused on animal health, operating in seven European countries as well as Australia and New Zealand and exporting to around 40 markets worldwide. The Group concentrates on bringing innovative veterinary products to market for companion, production and equine animals through its own development pipeline, partnerships and acquisitions.
Average Trading Volume: 226,197
Technical Sentiment Signal: Strong Buy
Current Market Cap: £175.4M
See more data about ANCR stock on TipRanks’ Stock Analysis page.